Latent transforming growth factor binding protein 4 (LTBP‐4) is downregulated in human mammary adenocarcinomas in vitro and in vivo
- 1 June 2007
- Vol. 115 (6) , 687-700
- https://doi.org/10.1111/j.1600-0463.2007.apm_453.x
Abstract
Transforming growth factor beta (TGF-ss) is able to inhibit proliferation of epithelial cells and is involved in the carcinogenesis of human mammary tumours. Three latent transforming growth factor-beta binding proteins (LTBP-1, -3 and -4) are involved in TGF-beta function. The aim of the study was to analyze the expression profiles of TGF-beta 1 and 2 and LTBP-4 in human mammary carcinoma cell lines as well as in human mammary tumours. Expression analysis was performed at the transcription and protein level under in vivo and in vitro conditions. LTBP-4 expression was quantitatively analysed in human carcinomas of the mammary gland and in healthy mammary tissues of the same patients. Downregulation of LTBP-4 in all investigated human mammary tumours compared to normal tissues could be demonstrated. Results also revealed that protein levels of TGF-beta 1 are downregulated and of TGF-beta 2 are upregulated in human mammary carcinoma cell lines compared to primary (normal) human mammary epithelial cells. LTBP-4 reduction in neoplasms leads to a possible decrease of TGF-beta 1 extracellular deposition with reduced TGF-beta 1 bioavailability. TGF-beta 2 was upregulated, which indicates a possible compensatory mechanism. This study demonstrated a possible functional role of LTBP-4 for TGF-beta bioavailability with respect to carcinogenesis of human mammary tumours in vivo and in vitro.Keywords
This publication has 32 references indexed in Scilit:
- Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor-α-positive Breast Cancer CellsJournal of Biological Chemistry, 2005
- Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lungThe Journal of cell biology, 2004
- Disruption of the gene encoding the latent transforming growth factor-β binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancerGenes & Development, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Evidence for the Decreased Expression of the Latent TGF-β Binding Protein and its Splice Form in Human Liver TumoursScandinavian Journal of Gastroenterology, 2001
- The latent transforming growth factor β binding protein (LTBP) familyBiochemical Journal, 2000
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- Independent Promoters Regulate the Expression of Two Amino Terminally Distinct Forms of Latent Transforming Growth Factor-β Binding Protein-1 (LTBP-1) in a Cell Type-specific MannerPublished by Elsevier ,1999
- Cellular and extracellular biology of the latent transforming growth factor-β binding proteinsMatrix Biology, 1998
- Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.Journal of Histochemistry & Cytochemistry, 1996